Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 4041-4050 Newer>

The Motley Fool August 20, 2007 Brian Lawler	Are These Perfect Pharma Acquisitions? Weighing recent drug-industry deals' odds of success: AstraZeneca and MedImmune... Shire and New River Pharmaceuticals... Gilead and Myogen...
The Motley Fool August 20, 2007 Brian Orelli	A Pain-Free FDA Announcement Anesiva gets approval for its new pain-reducing drug/device Zingo.
The Motley Fool August 20, 2007 Brian Orelli	Contracts That Are for the Birds Baxter and GlaxoSmithKline get bird flu vaccine contracts from the U.K. These contracts aren't reasons by themselves to run out and buy the companies' stock, but expanding income sources are almost always a good sign.
IEEE Spectrum August 2007 Joseph J. Morrissey	End the Mobile Phone Ban in Hospitals Here are the standards, and the argument, to let people use cellphones in hospitals.
Fast Company September 1, 2007 Ellen McGirt	Fast-Food Medicine Retail health clinics are dotting the landscape like Starbucks, frustrating doctors but delighting patients. Is this the beginning of the answer to our national health-care crisis?
The Motley Fool August 17, 2007 Brian Lawler	The Perfect Pharma Acquisition The pharmaceutical industry has been busy consolidating in the past year. With so much buying and selling going on, here is speculation on what would constitute the perfect pharma acquisition.
The Motley Fool August 17, 2007 Brian Orelli	Fewer Drug Approvals? Buy! Stricter standards at the FDA could create a buying opportunity. Drug approvals are down one third this year, creating a lot of value in pharmaceutical and biotech companies. Just choose your medicines carefully.
The Motley Fool August 17, 2007 Rich Smith	Foolish Forecast: Kensey Turn It Around? Analysts are looking for just a modest sales increase from Kensey Nash, maker of bio-absorbable arterial sealants, but Kensey hasn't met a target yet this year.
The Motley Fool August 17, 2007 Brian Orelli	FDA's Rigor May Boost Sales The FDA is updating labeling of certain blood-thinning drugs, indicating that patients may want to obtain a genetic test prior to taking the medication. This move may lead to increased testing, and hopefully increased prescriptions.
The Motley Fool August 16, 2007 Brian Orelli	Novacea's (Statistically) Significant Change The pharmaceutical increases the number of subjects in its latest clinical trial.
<Older 4041-4050 Newer> Return to current articles.